Today's health advances span cancer treatment optimization, obesity interventions, vaccine science refinement, infectious disease concerns, and improved therapeutics for autoimmune and sexually transmitted infections.

Fasting around chemotherapy improves ovarian cancer outcomes: A randomized trial found that women with ovarian cancer who fast before and after chemo show lower insulin levels, stronger tumor responses, and longer progression-free survival.

Cooling vest emerges as obesity treatment: Wearing a cooling vest for a few hours each morning may aid weight loss and reduce fat mass in adults with overweight or obesity, offering a non-pharmaceutical intervention option.

mRNA vaccine biology yields new insights: Scientists are discovering that approved mRNA vaccines work through different mechanisms than previously understood, with findings that could enhance future drug development while maintaining established safety profiles.

Cardiovascular disease diagnosis linked to increased cancer risk: A prospective study reveals that CVD diagnosis is associated with elevated cancer risk within the first year, particularly affecting women.

Andes virus transmission debate intensifies: Recent cruise ship outbreaks and cluster infections are prompting reconsideration of whether current precautions adequately address potential airborne respiratory spread of the dangerous pathogen.

Moxifloxacin outperforms standard treatment for M. genitalium: A 10-day course of moxifloxacin 400 mg daily demonstrates superior efficacy compared to the standard 6-day azithromycin regimen for sexually transmitted infection cure rates.

Belimumab reduces lupus flare risk: The immunosuppressive drug belimumab is linked to lower relapse risk in lupus patients with serositis, addressing a persistent clinical challenge despite initial anti-inflammatory therapy response.

Clinicians urged to assess endocrine disruptor exposure: Healthcare providers are advised to evaluate cumulative lifetime exposure to endocrine-disrupting chemicals in patients presenting with unexplained hormonal and metabolic symptoms.